Affigen Competitors and Similar CompaniesClear all
Aravive's competitors and similar companies include Kyowa Kirin.
 Aravive Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies. |  Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | |
Founding Date | Founding Date 2008 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Houston, US HQ | |
Employees | Employees 23 | Employees 5,669 |
Valuation ($) | Valuation ($) 2.9 m | Valuation ($) 8.8 b |
Financial | ||
Revenue (est.) | Revenue (est.) $9.1m (FY, 2022) | Revenue (est.) ¥496.8b (FY, 2025) |
Net income | Net income ($76.3m) (FY, 2022) | Net income ¥67b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Kyowa Kirin
HQ
Tokyo, JP
Employees
5,669
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company